Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis
- PMID: 17804612
- PMCID: PMC2168109
- DOI: 10.1128/CVI.00049-07
Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis
Abstract
Previous studies have identified the length dependency of several polysaccharide (PS) protective epitopes. We have investigated whether meningococcal polysaccharides Y and W-135 possess such epitopes. Oligosaccharides (OSs) consisting of one or more disaccharide repeating units (RU) were derived from the capsular PSs of group Y and W-135 meningococci (GYMP and GWMP, respectively) by mild acid hydrolysis. The relative affinities of anticapsular antibodies binding to derivative OSs of different chain lengths were measured in inhibition enzyme-linked immunosorbent assays. As OS size increased from two to three RU, there was a notable increase in binding inhibition of rabbit anti-group Y antiserum. This pattern of antibody binding inhibition was also observed for rabbit antiserum to group W-135, though the inhibition increase was much more pronounced. In the cases of both OS species, the concentration of inhibiting antigen required to achieve 50% inhibition of rabbit immunoglobulin binding increased progressively as the inhibiting disaccharide chain length increased from 1 RU through greater than 50 RU. These data suggest that antibodies directed against both of these meningococcal PSs recognize conformational epitopes only fully expressed in higher-molecular-weight forms of these antigens.
Figures
References
-
- Bardotti, A., G. Averani, F. Berti, S. Berti, C. Galli, S. Giannini, B. Fabbri, D. Proietti, N. Ravenscroft, and S. Ricci. 2005. Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135. Vaccine 23:1887-1899. - PubMed
-
- Bilukha, O. O., N. Rosenstein, and National Center for Infectious Diseases, Centers for Disease Control and Prevention. 2005. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices. Morb. Mortal. Wkly. Rep. Recomm. Rep. 54:1-21. - PubMed
-
- Brisson, J. R., S. Uhrinova, R. J. Woods, M. van der Zwan, H. C. Jarrell, L. C. Paoletti, D. L. Kasper, and H. J. Jennings. 1997. NMR and molecular dynamics studies of the conformational epitope of the type III group B Streptococcus capsular polysaccharide and derivatives. Biochemistry 36:3278-3292. - PubMed
-
- Centers for Disease Control and Prevention. 2000. Serogroup W-135 meningococcal disease among travelers returning from Saudi Arabia—United States, 2000. Morb. Mortal. Wkly. Rep. 49:345-346. - PubMed
-
- D'Ambra, A., J. E. Baugher, P. E. Concannon, R. A. Pon, and F. Michon. 1997. Direct and indirect methods for molar-mass analysis of fragments of the capsular polysaccharide of Haemophilus influenzae type b. Anal. Biochem. 250:228-236. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
